Lastly, since our EV purification did not use measures to enrich for cancer cell-derived EVs such as CD147 membrane presenting amplitude (Ko et al., 2023), we cannot exclude contamination of our miRNA data due to signals from non-cancer cell background, which might impact the cancer specificity of our proposed blood test. The gene discussed is BSG; the disease is cancer.